AbbVie and Simcere Zaiming, a subsidiary of Simcere Pharmaceutical Group Ltd., entered an option to license agreement to ...

In its latest attempt to bulk up its cancer drug portfolio, AbbVie has signed a new licensing agreement with China-based Simcere Zaiming to develop a treatment for myeloma, a type of blood cancer, in ...

SHANGHAI, China and NORTH CHICAGO, IL, USA I January 13, 2025 I Simcere Zaiming, a subsidiary of Simcere Pharmaceutical Group Ltd (HKEX: 2096) and AbbVie Inc.

Meet Dr. David Chung, Northwell Health's newest cancer care specialist. Learn about his priorities, challenges, and vision for personalized treatments ...

Ladenburg, Germany, 13 January 2025 – Heidelberg Pharma AG (FSE: HPHA), a clinical-stage biotech company developing innovative Antibody Drug Conjugates (ADCs), today announced that it is advancing ...

Sarclisa obtains first approval in China for the treatment of adult patients with relapsed or refractory multiple myelomaApproval based on ...

Dear Abby: I am a divorced woman who has recently decided to jump back into the dating pool. However, five years ago, I was ...

After experiencing unexplained symptoms, I was diagnosed with multiple myeloma and underwent a stem cell transplant.

AJ from the WPLR’s Chaz and AJ show revealed on the air last Monday that he recently has battled a variety of health issues ...

DEAR ABBY: I am a divorced woman who has recently decided to jump back into the dating pool. However, five years ago, I was ...

Dear Abby is written by Abigail Van Buren, also known as Jeanne Phillips, and was founded by her mother, Pauline Phillips.

The trial enrolled 531 adult subjects with multiple myeloma who had received at least one previous line of therapy.